Showing results (1341-1350 of 3,886) with videos related to
Sort By:
Pageof 389
Cancer Biology & Therapy|February 5, 2008
Aberrant activation of gamma-catenin promotes genomic instability and oncogenic effects during tumor progressionHongjie Pan, Fangming Gao, Panagiotis Papageorgis, et al.Cancer Biology & Therapy|August 25, 2004
Role of caveolin-1 in etoposide resistance development in A549 lung cancer cellsMartin M Bélanger, Martin Gaudreau, Elise Roussel, et al.Cancer Biology & Therapy|May 12, 2004
Gene expression profiling identifies markers of ampullary adenocarcinomaN Tjarda Van Heek, Anirban Maitra, Jens Koopmann, et al.Cancer Biology & Therapy|May 12, 2004
Histone deacetylase inhibitors are potent radiation protectantsLuca Paoluzzi, William D FiggCancer Biology & Therapy|July 16, 2004
Aqueous extract of Urtica dioica makes significant inhibition on adenosine deaminase activity in prostate tissue from patients with prostate cancerIlker Durak, Hasan Biri, Erdinç Devrim, et al.Cancer Biology & Therapy|March 9, 2005
Analysis of chromosomes 9 and 11 aneuploidy frequency in pleural effusion of patients with and without malignancy: interphase FISH techniqueTülin Cora, Hasan Acar, Sami Ceran, et al.Cancer Biology & Therapy|January 19, 2005
Selenomethionine regulates cyclooxygenase-2 (COX-2) expression through nuclear factor-kappa B (NF-kappaB) in colon cancer cellsDurga P Cherukuri, Anne-Christine Goulet, Hiroyasu Inoue, et al.Cancer Biology & Therapy|January 22, 2005
Genotyping and functional analysis of the D104N variant of human endostatinGordon R Macpherson, Arun S Singh, Charles L Bennett, et al.Cancer Biology & Therapy|January 22, 2005
The proteasome inhibitor bortezomib (PS-341) inhibits growth and induces apoptosis in primary effusion lymphoma cellsHittu Matta, Preet M ChaudharyCancer Biology & Therapy|March 9, 2005
The methods for determining the purity and in vitro or in vivo activity of recombinant human endostatinHong-Ying Zhang, Qing-Wang Han, Ye-Fen Xu, et al.Pageof 389